Terms: = Bone cancer AND RUNX1T1, ENSG00000079102, 862 AND Treatment
28 results:
1. Systemic Mastocytosis with Associated Hematological Neoplasms. Diagnostic features and unique response pattern to tyrosine kinase inhibitors and allo-bone marrow transplantation therapy.
Hernández Alconchel I; González de Villambrosía S; Insunza Gaminde A; Montes Moreno S
Rev Esp Patol; 2023; 56(3):180-185. PubMed ID: 37419556
[TBL] [Abstract] [Full Text] [Related]
2. The effect of long-acting somatostatin analogues on the uptake of [
Veerman CHAM; Siebinga H; de Vries-Huizing DMV; Tesselaar MET; Hendrikx JJMA; Stokkel MPM; Aalbersberg EA
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1434-1441. PubMed ID: 36598536
[TBL] [Abstract] [Full Text] [Related]
3. Acute myeloid leukemia patients with variant or unusual translocations involving chromosomes 8 and 21 - A comprehensive cytogenetic profiling of three cases with review of literature.
Akhila Raj TV; Gopinath P; Geetha Raj JA; Narayanan G; Nair SG; Joy Philip DS; Raveendran S; Geetha P; Sreedharan H
J Cancer Res Ther; 2022; 18(3):697-703. PubMed ID: 35900542
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathologic Characteristics Associated with Prognosis in Ocular Extranodal Marginal Zone B Cell Lymphoma.
Choi S; Seo M; Park SH; Jo JC; Chae SW; Lee JH; Cha HJ
Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744081
[No Abstract] [Full Text] [Related]
5. Dosimetric Comparison of Volumetric Modulated Arc Therapy and Intensity Modulated Radiation Therapy for Soft Tissue Sarcoma of the Extremities.
Lawless AK; Fangupo N; Estoesta RP; Perez G; Alzaidi S; Heller G; Hill R; Hong AM
Pract Radiat Oncol; 2022; 12(4):e306-e311. PubMed ID: 35278718
[TBL] [Abstract] [Full Text] [Related]
6. Prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study.
Hata H; Imamachi K; Ueda M; Matsuzaka M; Hiraga H; Osanai T; Harabayashi T; Fujimoto K; Oizumi S; Takahashi M; Yoshikawa K; Sato J; Yamazaki Y; Kitagawa Y
Support Care Cancer; 2022 May; 30(5):4505-4514. PubMed ID: 35113225
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic value of measurable residual disease at allogeneic transplantation for adults with core binding factor acute myeloid leukemia in complete remission.
Konuma T; Kondo T; Masuko M; Shimizu H; Shiratori S; Fukuda T; Kato J; Sawa M; Ozawa Y; Ota S; Uchida N; Kanda Y; Kako S; Fujisawa S; Fukushima K; Ichinohe T; Atsuta Y; Yanada M;
Bone Marrow Transplant; 2021 Nov; 56(11):2779-2787. PubMed ID: 34272486
[TBL] [Abstract] [Full Text] [Related]
8. Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry.
Shouval R; Fein JA; Labopin M; Cho C; Bazarbachi A; Baron F; Bug G; Ciceri F; Corbacioglu S; Galimard JE; Giebel S; Gilleece MH; Giralt S; Jakubowski A; Montoto S; O'Reilly RJ; Papadopoulos EB; Peric Z; Ruggeri A; Sanz J; Sauter CS; Savani BN; Schmid C; Spyridonidis A; Tamari R; Versluis J; Yakoub-Agha I; Perales MA; Mohty M; Nagler A
Lancet Haematol; 2021 Mar; 8(3):e205-e215. PubMed ID: 33636142
[TBL] [Abstract] [Full Text] [Related]
9. Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia.
Gottschalk Højfeldt S; Grell K; Abrahamsson J; Lund B; Vettenranta K; Jónsson ÓG; Frandsen TL; Wolthers BO; Marquart HV; Vaitkeviciene G; Lepik K; Heyman M; Schmiegelow K; Albertsen BK
Blood; 2021 Apr; 137(17):2373-2382. PubMed ID: 33150360
[TBL] [Abstract] [Full Text] [Related]
10. Japanese structure survey of radiation oncology in 2013.
Numasaki H; Teshima T; Okuda Y; Ogawa K;
J Radiat Res; 2020 Sep; 61(5):799-816. PubMed ID: 32648574
[TBL] [Abstract] [Full Text] [Related]
11. Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.
Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R;
Lancet Haematol; 2020 Feb; 7(2):e100-e111. PubMed ID: 31958417
[TBL] [Abstract] [Full Text] [Related]
12. Commonly Initiated Opioids and Risk of Fracture Hospitalizations in United States Nursing Homes.
Hunnicutt JN; Hume AL; Liu SH; Ulbricht CM; Tjia J; Lapane KL
Drugs Aging; 2018 Oct; 35(10):925-936. PubMed ID: 30187291
[TBL] [Abstract] [Full Text] [Related]
13. Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases.
Tomizawa D; Yoshida M; Kondo T; Miyamura T; Taga T; Adachi S; Koh K; Noguchi M; Kakuda H; Watanabe K; Cho Y; Fukuda T; Kato M; Shiba N; Goto H; Okada K; Inoue M; Hashii Y; Atsuta Y; Ishida H
Bone Marrow Transplant; 2019 Mar; 54(3):393-401. PubMed ID: 29959436
[TBL] [Abstract] [Full Text] [Related]
14. Abnormal DNA methylation may contribute to the progression of osteosarcoma.
Chen XG; Ma L; Xu JX
Mol Med Rep; 2018 Jan; 17(1):193-199. PubMed ID: 29115427
[TBL] [Abstract] [Full Text] [Related]
15. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM
Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688
[No Abstract] [Full Text] [Related]
16. Positional Accuracy of Treating Multiple Versus Single Vertebral Metastases With Stereotactic Body Radiotherapy.
Chang JH; Sangha A; Hyde D; Soliman H; Myrehaug S; Ruschin M; Lee Y; Sahgal A; Korol R
Technol Cancer Res Treat; 2017 Apr; 16(2):231-237. PubMed ID: 28279146
[TBL] [Abstract] [Full Text] [Related]
17. The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia.
Ouyang J; Goswami M; Tang G; Peng J; Ravandi F; Daver N; Routbort M; Konoplev S; Lin P; Medeiros LJ; Jorgensen JL; Wang SA
Am J Hematol; 2015 Jun; 90(6):504-10. PubMed ID: 25732229
[TBL] [Abstract] [Full Text] [Related]
18. treatment outcomes of temporal bone osteoradionecrosis.
Kammeijer Q; van Spronsen E; Mirck PG; Dreschler WA
Otolaryngol Head Neck Surg; 2015 Apr; 152(4):718-23. PubMed ID: 25560407
[TBL] [Abstract] [Full Text] [Related]
19. Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation.
Yoon JH; Kim HJ; Kim JW; Jeon YW; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Lee JW; Min WS; Park CW
Bone Marrow Transplant; 2014 Dec; 49(12):1466-74. PubMed ID: 25111512
[TBL] [Abstract] [Full Text] [Related]
20. Analysis of class I and II aberrations in Iraqi childhood acute myeloid leukemia using filter paper cards.
Al-Kzayer LF; Uyen le TN; Al-Jadiry MF; Al-Hadad SA; Al-Badri SA; Ghali HH; Ameen NA; Liu T; Matsuda K; Abdulkadhim JM; Al-Shujairi TA; Matti ZI; Hasan JG; Al-Abdullah HM; Al-Ani MH; Saber PA; Khalil HM; Inoshita T; Kamata M; Koike K; Sakashita K
Ann Hematol; 2014 Jun; 93(6):949-55. PubMed ID: 24464319
[TBL] [Abstract] [Full Text] [Related]
[Next]
